The New Era of Precision Therapy for Gastric Cancer: Focusing on Claudin 18.2, HER2, and Immune Checkpoint Inhibitors

Advances in Clinical Medicine 2026

View at publisher

Authors: 昱博王

DOI: 10.12677/acm.2026.162607

Cited by: 0

References: 27

Fields of Study & Subjects

Gastric Cancer Management and Outcomes Cancer Immunotherapy and Biomarkers HER2/EGFR in Cancer Research

References 27